Rapid Pathogen Screening

OverviewSuggest Edit

Rapid Pathogen Screening, Inc. (RPS) is an emerging developer, manufacturer, and marketer of rapid, point-of-care (POC) diagnostic tests.

RPS was founded in 2004 out of a joint venture between a family of Ophthalmologists and a German bio-technology company.

RPS’s business offices as well as its biosafety level 2 (BSL-2) laboratory are headquartered in Sarasota, Florida.

RPS is the proud inventor of a revolutionary, patented Direct Sampling Micro-Filtration (DSMF) and patent-pending Direct Multi-Planar Chromafiltography (DMC) technology. RPS tests have high sensitivity and specificity and provide rapid, easy to read results in 10 minutes. Utilizing RPS diagnostic tools enables clinicians to provide their patients with appropriate and timely treatment during the initial office visit. These rapid tests can reduce the number of future superfluous medical office visits and reduce healthcare costs associated with spread of disease and unnecessary treatments.

TypePrivate
Founded2004
HQSarasota, US
Websiterpsdetectors.com

Locations

Rapid Pathogen Screening is headquartered in
Sarasota, United States

Location Map

Latest Updates

Employees (est.) (Sept 2020)13
Cybersecurity ratingAMore

Key People/Management at Rapid Pathogen Screening

Kurt Phinney

Kurt Phinney

Senior Director of Operations
Craig Mallitz

Craig Mallitz

Non-Executive Director
James Lulo

James Lulo

Director of Product Development (R&D)
Randy Ross

Randy Ross

Senior Director of Finance and Human Resources
Benjamin S. Bergo

Benjamin S. Bergo

Non-Executive Director
Robert Sambursky

Robert Sambursky

President and Chief Executive Officer
Show more

Rapid Pathogen Screening Office Locations

Rapid Pathogen Screening has an office in Sarasota
Sarasota, US (HQ)
7227 Delainey Ct
Show all (1)

Rapid Pathogen Screening Financials and Metrics

Summary Metrics

Founding Date

2004

Rapid Pathogen Screening total Funding

$28 m

Rapid Pathogen Screening latest funding size

$28 m

Time since last funding

6 years ago
Rapid Pathogen Screening's latest funding round in October 2014 was reported to be $28 m. In total, Rapid Pathogen Screening has raised $28 m
Show all financial metrics

Rapid Pathogen Screening Cybersecurity Score

Cybersecurity ratingPremium dataset

A

91/100

SecurityScorecard logo

Rapid Pathogen Screening Online and Social Media Presence

Embed Graph

Rapid Pathogen Screening Blogs

Rapid Pathogen Screening Frequently Asked Questions

  • When was Rapid Pathogen Screening founded?

    Rapid Pathogen Screening was founded in 2004.

  • Who are Rapid Pathogen Screening key executives?

    Rapid Pathogen Screening's key executives are Kurt Phinney, Craig Mallitz and James Lulo.

  • How many employees does Rapid Pathogen Screening have?

    Rapid Pathogen Screening has 13 employees.

  • Who are Rapid Pathogen Screening competitors?

    Competitors of Rapid Pathogen Screening include Clementia Pharmaceuticals, ProtoKinetix and Magenta Therapeutics.

  • Where is Rapid Pathogen Screening headquarters?

    Rapid Pathogen Screening headquarters is located at 7227 Delainey Ct, Sarasota.

  • Where are Rapid Pathogen Screening offices?

    Rapid Pathogen Screening has an office in Sarasota.

  • How many offices does Rapid Pathogen Screening have?

    Rapid Pathogen Screening has 1 office.